Hans Hull, SVP, Business Operations at Avalanche Biotechnologies, Inc. ([AAVL]), sold 2,000 shares at $37.64 ($75K) on 2015-06-04, disclosed to the SEC on 2015-06-05.
Scheduled sale ($75k) by SVP, Business Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PLRX | SELL | 2024-01-19 | $337K | — | Filing → |
| PLRX | SELL | 2023-08-07 | $1.1M | — | Filing → |
| PLRX | SELL | 2023-07-19 | $646K | — | Filing → |